simendan has been researched along with MODS in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Q; Huang, D; Li, A; Li, B; Qin, J; Zhang, C; Zhang, X | 1 |
| Huang, HC; Ka, SM; Liaw, WJ; Tsai, HJ; Tsao, CM; Wang, CC; Wu, CC | 1 |
| García-García, AE; Mena-Arceo, RG; Ñamendys-Silva, SA; Rojo Del Moral, O | 1 |
| Ioannou, N; Meadows, C; Nandhabalan, P; Wyncoll, D | 1 |
| Ashby, D; Gordon, AC; Liu, KD; Mason, AJ; McAuley, DF; Morelli, A; Orme, RM; Perkins, GD; Singer, M | 1 |
| Chen, SJ; Huang, HC; Ka, SM; Li, KY; Liaw, WJ; Tsao, CM; Wu, CC | 1 |
| Graetz, TJ; Hotchkiss, RS | 1 |
| Janssens, U | 1 |
| Ertmer, C; Morelli, A; Westphal, M | 1 |
1 review(s) available for simendan and MODS
| Article | Year |
|---|---|
Meta-Analysis of the Efficacy of Levosimendan in the Treatment of Severe Sepsis Complicated with Septic Cardiomyopathy.
Topics: Adult; Calcium; Cardiomyopathies; Cardiotonic Agents; Humans; Hydrazones; Multiple Organ Failure; Pyridazines; Sepsis; Simendan; Stroke Volume; Ventricular Function, Left | 2023 |
1 trial(s) available for simendan and MODS
| Article | Year |
|---|---|
An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Critical Care; Diaphragm; Double-Blind Method; Follow-Up Studies; Humans; Hydrazones; Kidney; Multiple Organ Failure; Pyridazines; Regional Blood Flow; Research Design; Shock, Septic; Simendan | 2014 |
7 other study(ies) available for simendan and MODS
| Article | Year |
|---|---|
Levosimendan mitigates coagulopathy and organ dysfunction in rats with endotoxemia.
Topics: Animals; Blood Coagulation Disorders; Endotoxemia; Hydrazones; Interleukin-6; Lipopolysaccharides; Male; Multiple Organ Failure; Pyridazines; Rats; Rats, Wistar; Simendan; Thrombelastography | 2017 |
Organ Function Assessment, Prevention, and Outcomes in Critically Ill Patients with Sepsis.
Topics: Critical Illness; Humans; Multiple Organ Failure; Organ Dysfunction Scores; Sepsis; Simendan | 2018 |
Refractory septic shock: our pragmatic approach.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cardiotonic Agents; Extracorporeal Membrane Oxygenation; Humans; Immunoglobulins; Multiple Organ Failure; Renal Replacement Therapy; Serum Albumin, Human; Shock, Septic; Simendan; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model.
Topics: Animals; Disease Models, Animal; Hydrazones; Infusions, Intravenous; Male; Multiple Organ Failure; Oxidative Stress; Peritonitis; Pyridazines; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Simendan; Survival Rate | 2014 |
Sepsis: Preventing organ failure in sepsis - the search continues.
Topics: Humans; Multiple Organ Failure; Sepsis; Simendan; Treatment Failure; Vasodilator Agents | 2017 |
[Levosimendan-no effect on multiorgan failure in septic shock].
Topics: Cardiotonic Agents; Humans; Hydrazones; Multiple Organ Failure; Pyridazines; Shock, Septic; Simendan | 2017 |
Levo is in the air: take a deep breath!
Topics: Administration, Inhalation; Adult; Animals; Cardiotonic Agents; Disease Models, Animal; Female; Hemodynamics; Humans; Hydrazones; Multiple Organ Failure; Postoperative Complications; Pyridazines; Rats; Respiratory Distress Syndrome; Risk Factors; Shock, Septic; Simendan | 2008 |